Longitudinal Registry Including Patients Treated With Heavy Particles

Recruiting now

Conditions studied: Cancer, Oncology, Radiation Exposure, Radiotherapy Side Effect, Radiation Toxicity, Rare Disease

In brief

The purpose of this registry is to collect retrospective and prospective standardized data of patients treated with particle therapy, either with protons or carbon ions, at the National Center for Oncological Hadrontherapy (CNAO) based in Pavia. By keeping track of the patients treated, it will allow the investigators to periodically analyze and evaluate data collected of daily clinical activity. This will help gathering more information on the results of particle therapy and will provide the basis for in depth evaluation of patients' outcome with respect to the delivered treatment.

Key facts

Study ID

NCT05203250

Run by

CNAO National Center of Oncological Hadrontherapy

People needed

3000

Starts

2021-06-04

Expected to finish

2071-06-04

Last updated by the study team

2025-08-06

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients treated with heavy particles at Fondazione CNAO, Pavia
• Patients who have the ability to understand and be willing to sign a written informed consent document

You may not qualify if…

• Patients or legal guardians who are unable to understand informed consent document

Where it is running

• National Center for Oncological Hadrontherapy (CNAO) — Pavia, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.